Potential Drug Target: IFRD1 for Tissue Development, Cell Growth and Signaling Pathways

Target Name: IFRD1

NCBI ID: G3475

IFRD1

Potential Drug Target: IFRD1 for Tissue Development, Cell Growth and Signaling Pathways

IFRD1 (Integrin-Fc receptor type 1) is a protein that is expressed in many different tissues throughout the body. It is a member of the integrin family, which is a large family of transmembrane proteins that play a critical role in cell-cell and cell-extracellular matrix interactions. IFRD1 is one of the proteins that is encoded by the IFRD1 gene, which is located on chromosome 14.

IFRD1 is a protein that is made up of two transmembrane domains: an integrin domain and a ciliary (fiber) domain. The integrin domain is responsible for the protein's ability to interact with extracellular matrix (ECM) proteins, while the ciliary domain is involved in the protein's ability to move and interact with other cells.

IFRD1 is involved in many different processes throughout the body. For example, it is involved in the development and maintenance of tissues, such as skin and heart muscle. It is also involved in the regulation of cell growth and differentiation, as well as in the development and maintenance of blood vessels.

IFRD1 is a protein that has been identified as a potential drug target. Researchers have found that IFRD1 is involved in many different processes that are important for human health, and that it is possible to interfere with these processes using small molecules. This has led to the development of IFRD1 as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the reasons why IFRD1 has been identified as a potential drug target is that it is involved in many different processes that are important for human health. For example, IFRD1 is involved in the development and maintenance of tissues, such as skin and heart muscle . It is also involved in the regulation of cell growth and differentiation, as well as in the development and maintenance of blood vessels. These processes are important for maintaining the health and function of many different tissues in the body, and are therefore important targets for drugs that can interfere with them.

Another reason why IFRD1 has been identified as a potential drug target is that it is involved in the regulation of many different signaling pathways. For example, IFRD1 is involved in the regulation of the TGF-β pathway, which is a signaling pathway that is important for cell growth and differentiation. This means that IFRD1 is involved in many different processes that are important for human health, and that it is possible to interfere with these processes using small molecules.

IFRD1 is also a protein that has been shown to play a role in the development and progression of many different diseases. For example, IFRD1 has been shown to be involved in the development of cancer, and has been identified as a potential drug target for this disease. Similarly, IFRD1 has also been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Despite these promising findings, it is important to note that IFRD1 is not yet an approved drug target. Further research is needed to fully understand the role of IFRD1 in human health and to develop safe and effective drugs that can interfere with its activity. Additionally, research is also needed to understand the potential mechanisms of IFRD1 and how it interacts with other proteins.

In conclusion, IFRD1 is a protein that is involved in many different processes throughout the body. It is a member of the integrin family and is expressed in many different tissues. IFRD1 has been identified as a potential drug target due to its involvement in the development and maintenance of tissues, the regulation of cell growth and differentiation, and the regulation of many different pathways. Further research is needed to fully understand the role of IFRD1 in human health and to develop safe and effective drugs that can interfere with its activity.

Protein Name: Interferon Related Developmental Regulator 1

Functions: Could play a role in regulating gene activity in the proliferative and/or differentiative pathways induced by NGF. May be an autocrine factor that attenuates or amplifies the initial ligand-induced signal (By similarity)

The "IFRD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IFRD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets